1. Home
  2. HCM vs SYBT Comparison

HCM vs SYBT Comparison

Compare HCM & SYBT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HCM
  • SYBT
  • Stock Information
  • Founded
  • HCM 2000
  • SYBT 1904
  • Country
  • HCM Hong Kong
  • SYBT United States
  • Employees
  • HCM N/A
  • SYBT N/A
  • Industry
  • HCM Biotechnology: Pharmaceutical Preparations
  • SYBT Major Banks
  • Sector
  • HCM Health Care
  • SYBT Finance
  • Exchange
  • HCM Nasdaq
  • SYBT Nasdaq
  • Market Cap
  • HCM 2.5B
  • SYBT 2.3B
  • IPO Year
  • HCM N/A
  • SYBT N/A
  • Fundamental
  • Price
  • HCM $13.89
  • SYBT $73.56
  • Analyst Decision
  • HCM Hold
  • SYBT Hold
  • Analyst Count
  • HCM 1
  • SYBT 3
  • Target Price
  • HCM $19.00
  • SYBT $80.33
  • AVG Volume (30 Days)
  • HCM 62.8K
  • SYBT 101.6K
  • Earning Date
  • HCM 03-19-2025
  • SYBT 07-23-2025
  • Dividend Yield
  • HCM N/A
  • SYBT 1.69%
  • EPS Growth
  • HCM N/A
  • SYBT 16.29
  • EPS
  • HCM 0.04
  • SYBT 4.14
  • Revenue
  • HCM $630,201,000.00
  • SYBT $353,277,000.00
  • Revenue This Year
  • HCM $14.86
  • SYBT $14.39
  • Revenue Next Year
  • HCM $19.54
  • SYBT $5.04
  • P/E Ratio
  • HCM $63.20
  • SYBT $17.77
  • Revenue Growth
  • HCM N/A
  • SYBT 8.97
  • 52 Week Low
  • HCM $11.51
  • SYBT $45.01
  • 52 Week High
  • HCM $21.50
  • SYBT $79.85
  • Technical
  • Relative Strength Index (RSI)
  • HCM 50.07
  • SYBT 49.02
  • Support Level
  • HCM $13.13
  • SYBT $69.57
  • Resistance Level
  • HCM $13.66
  • SYBT $75.30
  • Average True Range (ATR)
  • HCM 0.36
  • SYBT 2.41
  • MACD
  • HCM 0.05
  • SYBT -0.52
  • Stochastic Oscillator
  • HCM 81.25
  • SYBT 44.09

About HCM HUTCHMED (China) Limited

HUTCHMED (China) Ltd is an innovative biopharmaceutical company engaged in the discovery, global development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies around the world and extensive commercial infrastructure in its home market of China. The company operates in two reportable segments Oncology/Immunology, and Other Ventures.

About SYBT Stock Yards Bancorp Inc.

Stock Yards Bancorp Inc operates as a bank. The bank has two reportable operating segments namely Commercial Banking and Wealth Management and Trust. Its services include loan and deposit services, cash management services, securities brokerage activities, mortgage origination, and others. It generates the majority of its revenue from the Commercial Banking segment.

Share on Social Networks: